These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 984808)

  • 1. Concentration of cefamandole in serum interstitial fluid, bile, and urine.
    Waterman NG; Eickenberg HU; Scharfenberger L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):733-5. PubMed ID: 984808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration relationships of cefaclor in serum, interstitial fluid, bile, and urine of dogs.
    Waterman NG; Scharfenberger LF
    Antimicrob Agents Chemother; 1978 Oct; 14(4):614-6. PubMed ID: 718157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.
    Carbon C; Contrepois A; Brion N; Lamotte-Barrillon S
    Antimicrob Agents Chemother; 1977 Apr; 11(4):594-8. PubMed ID: 856011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalothin and cefamandole penetration into bone, synovial fluid, and wound drainage fluid.
    Schurman DJ; Hirshman HP; Burton DS
    J Bone Joint Surg Am; 1980 Sep; 62(6):981-5. PubMed ID: 7430187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probenecid on the blood levels and urinary excretion of cefamandole.
    Griffith RS; Black HR; Brier GL; Wolny JD
    Antimicrob Agents Chemother; 1977 May; 11(5):809-12. PubMed ID: 879735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
    Ratzan KR; Baker HB; Lauredo I
    Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefamandole: in vitro and clinical pharmacokinetics.
    Griffith RS; Black HR; Brier GL; Wolny JD
    Antimicrob Agents Chemother; 1976 Nov; 10(5):814-23. PubMed ID: 1008540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations in man on some pharmacologic features of cefamandole.
    Grose WE; Bodey GP; Stewart D
    Clin Pharmacol Ther; 1976 Nov; 20(5):579-84. PubMed ID: 975730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cephalosporins with human and canine serum proteins.
    Peterson LR; Gerding DN
    J Infect Dis; 1978 Apr; 137(4):452-7. PubMed ID: 649989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.
    Barza M; Melethil S; Berger S; Ernst EC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):421-5. PubMed ID: 984783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of cefamandole as compared with cephalothin.
    Fong IW; Ralph ED; Engelking ER; Kirby WM
    Antimicrob Agents Chemother; 1976 Jan; 9(1):65-9. PubMed ID: 1259393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of [14C]cefamandole, a parenteral cephalosporin antibiotic, in rats and dogs.
    Sullivan HR; Due SL; Kau DL; Quay JF; Miller WM
    Antimicrob Agents Chemother; 1977 Jul; 12(1):73-9. PubMed ID: 883820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefamandole bile levels in patients with hepatobiliary disease.
    Uwaydah M; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1087-9. PubMed ID: 7159070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical study of the biliary excretion of cefamandole (author's transl)].
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Adloff M; Lavillaureix J
    Pathol Biol (Paris); 1981 Jan; 29(1):25-30. PubMed ID: 7010273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefamandole in patients with renal failure.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefamandole in osseous tissue.
    Lunke RJ; Fitzgerald RH; Washington JA
    Antimicrob Agents Chemother; 1981 May; 19(5):851-8. PubMed ID: 7294769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.
    Gerding DN; Peterson LR; Legler DC; Hall WH; Schierl EA
    Antimicrob Agents Chemother; 1978 Aug; 14(2):234-9. PubMed ID: 697350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots.
    Bergeron MG; Nguyen BM; Trottier S; Gauvreau L
    Antimicrob Agents Chemother; 1977 Dec; 12(6):682-7. PubMed ID: 931366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.